DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION PATIENTS WITH LOW, MODERATE AND HIGH CHADS2 SCORE: A RE-LY SUBGROUP ANALYSIS

被引：0
|
作者：
Oldgren, Jonas
Alings, Marco
Darius, Harald
Eikelboom, John
Ezekowitz, Michael
Parekh, Amit
Pogue, Janice
Reilly, Paul
Yusuf, Salim
Wallentin, Lars
Connolly, Stuart
机构：
[1] Uppsala Clin Res Ctr, Uppsala, Sweden
[2] Populat Hlth Res Inst, Hamilton, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0903-04
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
    Oldgren, Jonas
    Alings, Marco
    Darius, Harald
    Diener, Hans-Christoph
    Eikelboom, John
    Ezekowitz, Michael D.
    Kamensky, Gabriel
    Reilly, Paul A.
    Yang, Sean
    Yusuf, Salim
    Wallentin, Lars
    Connolly, Stuart J.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (10) : 660 - +
  • [2] DABIGATRAN ETEXILATE VERSUS WARFARIN IN PATIENTS WITH DIFFERENT TYPES OF ATRIAL FIBRILLATION: A RE-LY® SUBGROUP ANALYSIS
    Flaker, Greg C.
    Reilly, Paul
    Yusuf, Salim
    Ezekowitz, Mike
    Wallentin, Lars
    Brueckmann, Martina
    Connolly, Stuart
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E62 - E62
  • [3] DABIGATRAN VERSUS WARFARIN AND IMPACT OF CHAD2-VASC SCORE ON OUTCOME IN ATRIAL FIBRILLATION PATIENTS: A RE-LY SUBGROUP ANALYSIS
    Oldgren, Jonas
    Ezekowitz, Michael D.
    Alings, Marco
    Diener, Hans-Christoph
    Reilly, Paul A.
    Yusuf, Salim
    Wallentin, Lars
    Connolly, Stuart
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E7 - E7
  • [4] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. Results of the RE-LY study
    不详
    KARDIOLOGIYA, 2009, 49 (10) : 75 - 76
  • [5] Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial
    Khoo, Chee W.
    Lip, Gregory Y. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 685 - 687
  • [6] Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial
    Ferreira, Jorge
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    Brueckmann, Martina
    Fraessdorf, Mandy
    Reilly, Paul A.
    Yusuf, Salim
    Wallentin, Lars
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (09) : 1053 - 1061
  • [7] Efficacy and Safety of Dabigatran Versus Warfarin in Patients with Atrial Fibrillation: Analysis in Asian Population in RE-LY Trial
    Hori, M.
    Connolly, S. J.
    Zhu, J.
    Liu, L. S.
    Lau, C-P
    Pais, P.
    Xavier, D.
    Kim, S. S.
    Omar, R.
    Dans, A. L.
    Tan, R. S.
    Chen, J-H
    Tanomsup, S.
    Watanabe, M.
    Koyanagi, M.
    Ezekowitz, M. D.
    Reilly, P. A.
    Wallentin, L.
    Yusuf, S.
    CEREBROVASCULAR DISEASES, 2012, 34 : 9 - 9
  • [8] Comparison of Dabigatran versus Warfarin in Diabetic Patients with Atrial Fibrillation: Results from the RE-LY Trial
    Darius, Harald
    Clemens, Andreas
    Healey, Jeff S.
    Avezum, Alvaro
    Nagarakanti, Rangadham
    Chin, Ashley
    Noack, Herbert
    Connolly, Stuart
    CIRCULATION, 2012, 126 (21)
  • [9] Efficacy and Safety of Dabigatran Etexilate vs. Warfarin in Asian RE-LY Patients According to Baseline Renal Function or CHADS2 Score
    Hori, Masatsugu
    Fukaya, Taku
    Kleine, Eva
    Reilly, Paul A.
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    CIRCULATION JOURNAL, 2015, 79 (10) : 2138 - 2147
  • [10] Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial
    Brambatti, Michela
    Darius, Harald
    Oldgren, Jonas
    Clemens, Andreas
    Noack, Herbert H.
    Brueckmann, Martina
    Yusuf, Salim
    Wallentin, Lars
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    Healey, Jeff S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 196 : 127 - 131
12345